The GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTNEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
CBL-514 20mg research product
Shipping batchSelect size

Metabolic Research

CBL-514 20mg

CBL-514 20 mg is supplied as a powder in a vial for laboratory research. CBL-514 is the name of an investigational small molecule studied in adipose-tissue research. The labeled amount is 20 mg per vial, not a concentration or a batch-assay result.

In stock · ready to shipEarn 399 points
Pack
Quantity
1
$399.99
Save 10% with code WELCOME10 at checkout
Your purchasing batch
CBL01
Certificates for published lots are in the COA library
COA
Referral program · researchers save 10%, you earn 15% back
FedEx 2-Day shipping
Free on orders over $250
Ships from the US West Coast
Tracked delivery on every order
Per-batch COA access
Every order ships with certificate access for its lot
Secure encrypted checkout CASH APP 5% OFFZELLE 5% OFFBANK TRANSFER 5% OFFCHIME 5% OFFCRYPTO 7% OFFVISA · AMEX NO FEE

More ways to save

Bulk Orders By quote

Larger runs, institutional supply and custom timelines are priced by quote. Send the quantity and the timeline and we will come back with a number.

Ask about bulk

Select a product option

Choose a size to check its batch and certificate. Published reports remain available below; check the lot before using a report.

Additional published certificates

Verified test results

Every batch, independently verified.

Each batch is analyzed by Freedom Diagnostics, an independent third-party laboratory, before release. Below is the report for lot CBL01, summarized from the certificate the lab published.

FRE
Freedom Diagnostics
Independent third-party laboratory
Certificate of Analysis · 2611111049
Lot
CBL01
Tested
Nov 13, 2026 (report date)
Labeled
20mg
Independent third-party lab
MethodLC-MS; endotoxin; microbial PCR; ICP-MS
IssuedNov 13, 2026 · signed by the principal chemist
CBL-514 20mg certificate of analysisOpen the CBL01 certificate
View the signed certificate →
Certificate results✓ 2 passed · 2 reported without a verdict
Identity
LC-MS
Curcumin / Trans-Resveratrol
Reported in four samples
Endotoxins
Limulus Amebocyte Lysate
Pass
Two replicates; assay sensitivity <=0.05 EU/mL
PASS
Microbial DNA
PCR
No Detectable Microbial DNA
Not a sterility test
Elemental impurities
ICP-MS
As, Cd, Pb and Hg below limits
Per source report
PASS

Every batch on record

This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.

Open the COA portal →

Side by side

How Disguised compares.

Disguised
Typical supplier
Per-batch third-party COA
Yes
Rarely provided
Independent third-party testing
Yes
Inconsistent
HPLC + mass-spec verified
Yes
Often unverified
Endotoxin tested
Yes
Rarely
Made & tested in the USA
Yes
Often overseas
Discreet, tracked shipping
Yes
Varies

Technical specifications

Compound Information

Read the CBL-514 20mg research guide
Storage Requirements

Stability information.

Avoid freeze/thaw cyclesProtect from lightRefrigerate after reconstitution
−20°C
Lyophilized powder, as shipped
The most stable form. Store cold and protected from light until it is reconstituted.
2–8°C
After reconstitution
Refrigerate once reconstituted and keep it protected from light.

Important research notice

Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.

All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.

By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.

Ready when you are

Nothing ships without paperwork. Every lot is on record.

The lot on this page links to the signed certificate for that batch.

1Lot on record
1Independent lab
Loading...
✓
View Full Product Description

Research material

CBL-514 20mg: product details and research reference

CBL-514 20 mg: research compound and evidence overview

CBL-514 20 mg is supplied as a powder in a vial for laboratory research. CBL-514 is the name of an investigational small molecule studied in adipose-tissue research. The labeled amount is 20 mg per vial, not a concentration or a batch-assay result.

What is CBL-514?

Caliway describes its investigational CBL-514 as a small-molecule drug candidate, rather than a peptide. Its development program examines localized subcutaneous fat reduction and other adipose-tissue conditions. Research on the developer's clinical formulation does not establish the identity, formulation, purity, safety or efficacy of this separately supplied research material. Disguised Alpha is not claiming affiliation with Caliway. Developer's CBL-514 research program.

CBL-514 mechanism: adipocyte apoptosis

Adipocytes are fat-storing cells; apoptosis is programmed cell death. Caliway's preclinical research describes changes in caspase-3 and the Bax/Bcl-2 ratio associated with adipocyte apoptosis. These findings explain the research interest in CBL-514, but do not demonstrate that an unverified commercial vial has the same composition or biological activity as the investigational formulation. Caliway's mechanism and study background.

Published CBL-514 studies

The evidence includes early clinical studies of the developer's investigational formulation. Study design, population, measurement method and follow-up matter when comparing findings:

2022 Phase IIa studyGoodman and colleagues examined abdominal subcutaneous fat using ultrasound in an open-label study with random allocation. Its design and limited follow-up should be considered when interpreting the findings. PubMed PMID 35709509; DOI 10.1093/asj/sjac162.
2025 placebo-controlled Phase II studyGold and colleagues randomized 76 participants and evaluated abdominal subcutaneous fat with ultrasound. The reported results concern the study formulation and population. Injection-site reactions were the most common treatment-emergent adverse events. PubMed PMID 40037659; DOI 10.1093/asj/sjaf032.
2026 Phase IIb studyLorenc and colleagues randomized 108 adults and assessed clinician-reported and participant-reported abdominal fat ratings alongside MRI measurements. These endpoints differ from the ultrasound endpoints used in earlier studies. PubMed PMID 42159040; DOI 10.1093/asj/sjag092.

Subcutaneous versus visceral fat research

Subcutaneous fat lies beneath the skin, while visceral fat surrounds internal organs. A 2026 EASD report described an exploratory MRI subgroup analysis drawn from CBL-514 Phase II trials. It should be read as preliminary subgroup evidence, separately from the trials' primary subcutaneous-fat endpoints. It is not proof of a predictable fat-loss result from this research product. Caliway's October 2, 2026 EASD report and study limitations.

CBL-514 product specifications

ProductCBL-514
Labeled amount20 mg per vial
FormatPowder
SKUCBL514
Intended useLaboratory research only

Certificate of analysis and batch verification

Match the batch identifier on the supplied vial to its certificate of analysis (COA). Check the report's sample identity, laboratory, analytical method, report date and measured results. Labeled mass, measured content and chromatographic purity are different specifications. A product photograph, QR code or published study does not replace a matching batch report.

Batch CBL01: View the Freedom Diagnostics COA, accession 2611111049, reported November 13, 2026. This corrected report identifies curcumin and trans-resveratrol by LC-MS in four samples and reports passing endotoxin and elemental-impurity results, with no detectable microbial DNA by PCR. It does not report a purity percentage or quantified total content; the 20 mg product label is not a measured result from this certificate. PCR findings do not establish sterility. The report does not establish equivalence to Caliway’s investigational formulation. See the COA portal for the source report.

Does 20 mg mean 20 mg/mL?

No. The 20 mg label states an amount per vial. A concentration in mg/mL also requires a defined solution volume; it cannot be inferred from the vial size or product name. No preparation or administration protocol is provided here.

Is this the same as the CBL-514 used in clinical trials?

Equivalence has not been established. Published results apply to the investigational material used in each study. A matching name does not prove that a separately supplied powder has the same formulation, manufacturing controls or clinical performance.

Is CBL-514 offered for human use?

No. This listing is for laboratory research only, not for human consumption, self-administration, veterinary, diagnostic or therapeutic use. Clinical development information is research context and is not a claim that this product is an approved medicine.

Explore the CBL-514 research library

Read 20 source-linked articles on CBL-514 identity, mechanism, clinical study design, evidence interpretation and research-material documentation. Each article separates the developer’s study findings from the specifications of this separately supplied laboratory material.

Related research and documentation

Explore the CBL-514 research guide, metabolic research collection, COA portal and research editorial standards. Sources reviewed October 30, 2026.

Documentation and research handling

Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.

Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.

Product questions

Which product details should I check?

Match the compound or ingredient identity, format, labeled quantity and shipping lot. Similar names or different formulations should not be treated as equivalent.

Where is the batch-specific evidence?

Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.

View Currently Shipping CoA

The current certificate is matched to the selected product option and assigned shipping batch.

Enable JavaScript to view the certificate for your selected option.

25% offGLPs15% off automaticallyUse code GLP or any code for 25% off0days00hrs00min00secShop the sale  →Shop